SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001566044-21-000037
Filing Date
2021-11-10
Accepted
2021-11-10 08:29:18
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vyne-20210930.htm   iXBRL 10-Q 1251174
2 EX-10.1 exhibit101-vynexin4dermxto.htm EX-10.1 399795
3 EX-10.2 exhibit102-in4dermxvynexev.htm EX-10.2 146299
4 EX-31.1 vyne-20210930xexx311.htm EX-31.1 9711
5 EX-31.2 vyne-20210930xexx312.htm EX-31.2 9705
6 EX-32.1 vyne-20210930xexx321.htm EX-32.1 5289
7 EX-32.2 vyne-20210930xexx322.htm EX-32.2 5280
  Complete submission text file 0001566044-21-000037.txt   6896704

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20210930.xsd EX-101.SCH 43847
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20210930_cal.xml EX-101.CAL 69451
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20210930_def.xml EX-101.DEF 252879
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20210930_lab.xml EX-101.LAB 590346
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20210930_pre.xml EX-101.PRE 391561
13 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20210930_htm.xml XML 895399
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 211394551
SIC: 2834 Pharmaceutical Preparations